A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Recruiting now · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Non Small Cell Lung Cancer (Squamous or Non Squamous), Stage 4 NSCLC
In brief
This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chemotherapy for patients with stage 4 NSCLC.
Key facts
- Study ID
- NCT07365319
- Run by
- Eikon Therapeutics
- People needed
- 750
- Starts
- 2026-06-15
- Expected to finish
- 2040-12-31
- Last updated by the study team
- 2026-08-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Southern Cancer Center, P.C. — Daphne, Alabama, United States (enrolling)
- Los Angeles Cancer Network — Glendale, California, United States (enrolling)
- Providence St. Joseph Hospital — Orange, California, United States (enrolling)
- Rocky Mountain Cancer Centers, LLP — Pueblo, Colorado, United States (enrolling)
- University of New Mexico - Comprehensive Cancer Center — Albuquerque, New Mexico, United States (enrolling)
- NYU Langone Hospital Long Island — Mineola, New York, United States (enrolling)
- NYU Langone Hospital Manhattan — New York, New York, United States (enrolling)
- Jacobi Medical Center - Albert Einstein College of Medicine — The Bronx, New York, United States (enrolling)
- White Plains Hospital — White Plains, New York, United States (enrolling)
- Blue Ridge Cancer Center — Blacksburg, Virginia, United States (enrolling)
- Virginia Cancer Specialists, PC — Fairfax, Virginia, United States (enrolling)
- Shenandoah Oncology P.C. — Winchester, Virginia, United States (enrolling)
- Hospital Universitario de Jerez de la Frontera — Jerez de la Frontera, Cadiz, Spain (enrolling)
- Institut Catala D'Oncologia de Girona — Girona, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.